中国现代医生
中國現代醫生
중국현대의생
CHINA MODERN DOCTOR
2009年
17期
135-136
,共2页
尼莫地平%偏头痛%钙离子拮抗剂%太极通天口服液
尼莫地平%偏頭痛%鈣離子拮抗劑%太極通天口服液
니막지평%편두통%개리자길항제%태겁통천구복액
Nimodipine%Migraine%Calcium antagonist%Taiji Tongtian oral solution
目的 探讨太极通天121服液合用尼莫地平治疗偏头痛的疗效.方法 60例患者随机分为治疗组和对照组各30例,治疗组给予太极通天口服液10mL,每日3次,尼莫地平40mg,每日3次,口服,3周为-个疗程,对照组给予尼莫地平40mg,每日3次,口服,3周为一疗程.结果 治疗组与对照组疗效比较差异显著(P<0.05).结论 太极通天口服液合用尼莫地平治疗偏头痛疗效显著,副作用少,安全性高,值得临床推广.
目的 探討太極通天121服液閤用尼莫地平治療偏頭痛的療效.方法 60例患者隨機分為治療組和對照組各30例,治療組給予太極通天口服液10mL,每日3次,尼莫地平40mg,每日3次,口服,3週為-箇療程,對照組給予尼莫地平40mg,每日3次,口服,3週為一療程.結果 治療組與對照組療效比較差異顯著(P<0.05).結論 太極通天口服液閤用尼莫地平治療偏頭痛療效顯著,副作用少,安全性高,值得臨床推廣.
목적 탐토태겁통천121복액합용니막지평치료편두통적료효.방법 60례환자수궤분위치료조화대조조각30례,치료조급여태겁통천구복액10mL,매일3차,니막지평40mg,매일3차,구복,3주위-개료정,대조조급여니막지평40mg,매일3차,구복,3주위일료정.결과 치료조여대조조료효비교차이현저(P<0.05).결론 태겁통천구복액합용니막지평치료편두통료효현저,부작용소,안전성고,치득림상추엄.
Objective To investigate the combined Taiji Tongtian oral solution of nimodipine in the treatment of migraine treatment. Meth-ods 60 cases were randomly divided into treatment and control group 30 cases,treatment given to the treatment group Taiji Tongtian oral so-lution 10ml,3 times a day Nimodipine 40mg,3 times a day,oral,three weeks into a course of treatment. The control group Nimodipine 40mg,3 times a day,oral,three weeks into a course of treatment. Results The treatment group and control group had significantly different effects (P < 0.05). Conclusion The combination Taiji Tongtian oral solution and nimodipine in the treatment of migraine has significant effect,no adverse reactions, high security and is worthy popularizing in clinic.
